Diabetes
From the Journals
Dapagliflozin’s cost-effectiveness ‘intermediate’ for HFrEF
Conference Coverage
Prediabetes linked to higher CVD and CKD rates
Data from more than 330,000 U.K. adults show that an A1c of 5.7%-6.4% links with higher rates of incident CKD and CVD events.
From the Journals
Pericardial fat an independent risk factor for heart failure
Fat around the heart has been linked to an increased risk for heart failure, particularly in women, suggests a study using CT scans from nearly 7,...
Conference Coverage
‘A better picture’: First AACE guidelines on diabetes technology
Current knowledge on insulin pumps, continuous glucose monitors, automated insulin delivery systems, ‘smart’ pens, telemedicine, apps, and...
Conference Coverage
Semaglutide boosts weight loss following endoscopic gastroplasty
Five patients in the combination group reverted to a nondiabetic state and were able to discontinue antidiabetic medications altogether.
News
FDA panel endorses teplizumab for delaying type 1 diabetes
Teplizumab interferes with T cell–mediated autoimmune destruction of pancreatic beta cells.
From the Journals
‘Overbasalization’ common in type 2 diabetes management
There are alternatives to giving insulin before meals to...
Conference Coverage
Daily cup of coffee cuts type 2 diabetes risk by about 5%
Beneficial effects may be caused by coffee’s ability to reduce inflammation.
From the Journals
Mild cortisol excess increases mortality in adrenal incidentaloma
Autonomous cortisol secretion level following dexamethasone suppression test in patients with adrenal incidentalomas, but without Cushing syndrome...
50th Anniversary
First issue vs. April 2021 issue: Much has changed since 1971
50-year journey through the world of family medicine has taken us from oral contraceptives to COVID-19.
Conference Coverage
Sotagliflozin’s HFpEF benefit confirmed by new analyses